Bionomics (BNOEF) News Today $0.0034 0.00 (-43.33%) As of 09/19/2023 Add Compare Share Share Headlines Stock AnalysisBuy This Stock BNOEF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Neuphoria Therapeutics More Than Doubles After Bionomics Re-DomiciliationDecember 25, 2024 | marketwatch.comBionomics announces Australia Supreme Court approves re-domiciliationDecember 17, 2024 | markets.businessinsider.comBionomics Announces Supreme Court of New South Wales Approves Bionomics’ Re-DomiciliationDecember 16, 2024 | markets.businessinsider.comBionomics publishes resuls from Phase 2 ATTUNE study of BNC210December 9, 2024 | markets.businessinsider.comBionomics to Present at the 2024 CNS SummitNovember 7, 2024 | markets.businessinsider.comWhy Bionomics (BNOX) Stock Is Up 100% TodayNovember 5, 2024 | benzinga.comBionomics Receives Milestone Payment of AUS$1M from Carina Biotech for BNC101 Partnered Legacy Oncology ProgramNovember 4, 2024 | markets.businessinsider.comBionomics Issues Shareholder Letter Highlighting Recent Achievements and Strategic VisionOctober 7, 2024 | finance.yahoo.comBionomics Plans Re-domiciliation - Quick FactsOctober 1, 2024 | markets.businessinsider.comJamaican-style beef and pepper stir fryAugust 3, 2024 | bbc.co.ukBionomics initiates screening for social anxiety disorder therapy trialJuly 20, 2024 | finance.yahoo.comKendrick Lamar’s beef with Drake and J Cole explainedMay 9, 2024 | bbc.comBChilli beef udon noodlesApril 17, 2024 | bbc.co.ukBionomics to advance non-SSRI PTSD candidate to Phase IIIMarch 21, 2024 | msn.comBionomics to Present at Biotech Showcase™ 2024January 5, 2024 | tmcnet.comPeter Bone MP loses seat as recall petition triggers by-electionDecember 30, 2023 | bbc.co.ukBionomics presents data on reliability of the Subjective Units of Distress ScaleDecember 6, 2023 | msn.comBionomics Secures Buy Rating Amidst Promising BNC210 Developments and Potential Market Entry AdvantageOctober 16, 2023 | markets.businessinsider.comBionomics stock rockets 415% on positive study for PSTD drugSeptember 29, 2023 | msn.comBionomics shares soar almost 400% after positive phase IIb results from PTSD treatmentSeptember 28, 2023 | proactiveinvestors.comBionomics Shares Take Flight on Positive PTSD Study ResultsSeptember 28, 2023 | marketwatch.comBionomics Shares Rally Premarket on Phase 2B PTSD Study SuccessSeptember 28, 2023 | marketwatch.comBionomics: Phase 2b ATTUNE Trial With BNC210 Meets Primary Endpoint - Quick FactsSeptember 28, 2023 | markets.businessinsider.comBionomics announces positive results in trial of treatment for PTSDSeptember 28, 2023 | msn.comJay Norvell's beef with Deion Sanders and Colorado is so good for college footballSeptember 26, 2023 | ftw.usatoday.comBionomics Announces Update on the α7 Nicotinic Acetylcholine Receptor (nAChR) Positive Allosteric Modulator (PAM) Collaboration with MSDSeptember 14, 2023 | finance.yahoo.comMike Trout suffers broken hamate bone, likely out six to eight weeksJuly 9, 2023 | usatoday.comBionomics Announces the Completion of Enrollment in Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)April 27, 2023 | finance.yahoo.comPositive Report for Bionomics (BNOX) from Evercore ISIMarch 10, 2023 | markets.businessinsider.comBionomics Reports Promising Full Results Analysis from PREVAIL Phase 2 Study of BNC210 Social Anxiety Disorder (SAD)March 8, 2023 | finance.yahoo.comBears are Losing Control Over Bionomics Limited Unsponsored ADR (BNOX), Here's Why It's a 'Buy' NowMarch 3, 2023 | msn.comBionomics Limited (BNOEF) Stock Historical Prices & Data - Yahoo FinanceFebruary 10, 2023 | finance.yahoo.comBionomics Names Spyridon Papapetropoulos as President, CEODecember 15, 2022 | marketwatch.comBionomics appoints Spyridon “Spyros” Papapetropoulos as President and Chief Executive OfficerDecember 15, 2022 | finance.yahoo.comBionomics Limited Announces Closing of US$5 Million Underwritten Offering of American Depositary Shares in the United StatesNovember 21, 2022 | nz.finance.yahoo.comBionomics Shares Drop 18% After ADS Offering PricesNovember 17, 2022 | marketwatch.comBionomics receives R&D tax incentive refund for FY22 of A$4.6MOctober 18, 2022 | seekingalpha.comBionomics to Host KOL Webinar on BNC210 and Social Anxiety DisorderSeptember 21, 2022 | technews.tmcnet.comNovamind to Host Bionomics' PREVAIL Trial for Acute Treatment of Social Anxiety DisorderMay 10, 2022 | stockhouse.comBionomics Phase 2 Study for Social Anxiety BeginsJanuary 3, 2022 | marketwatch.comBionomics Initiates Phase 2 PREVAIL Study of BNC210 for the Acute Treatment of Social Anxiety DisorderJanuary 3, 2022 | prnewswire.comBionomics Ltd. - ADR Shares Near 52-Week Low - Market MoverDecember 26, 2021 | nasdaq.comAustralian biotech Bionomics files for IPO with plans to list on NasdaqNovember 23, 2021 | markets.businessinsider.comBionomics Files Registration Statement for Proposed Initial Public Offering in the United StatesNovember 23, 2021 | finance.yahoo.comAustralia's Bionomics Ltd. Files for IPO With U.S. SECNovember 22, 2021 | morningstar.comMGlobal Hemp : Completes Due Diligence on Its 664 Acre Property and Initiates Detailed Design Strategies for Its Planned Green Community in Hayden Colorado - Marketscreener.comSeptember 24, 2021 | marketscreener.comMThese 3 ASX Healthcare shares have soared over 10% today - The Motley Fool AustraliaSeptember 24, 2021 | fool.com.auGlobal Psychiatry Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021 - PRNewswireSeptember 23, 2021 | prnewswire.comBionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial - PRNewswireSeptember 20, 2021 | prnewswire.comNovamind to Serve as Research Site for Karuna Therapeutics Late-Stage Clinical Trial - StreetInsider.comSeptember 13, 2021 | streetinsider.com Get Bionomics News Delivered to You Automatically Sign up to receive the latest news and ratings for BNOEF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BNOEF Media Mentions By Week BNOEF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNOEF News Sentiment▼0.000.77▲Average Medical News Sentiment BNOEF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNOEF Articles This Week▼01▲BNOEF Articles Average Week Get the Latest News and Ratings for BNOEF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Bionomics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Natural Alternatives International News Scienture News enVVeno Medical News PharmChem News Edesa Biotech News NeuroSense Therapeutics News Tharimmune News Envoy Medical News Athira Pharma News iBio News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BNOEF) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia and AMD just surged. But this setup was already winning.Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | SponsoredHave you heard of the Texas Royalty Plan?There is a backdoor way you could collect a check, four times a year, thanks to the exploding oil industry in ...Brownstone Research | SponsoredHow to Cash In on Trump’s Digital Current - Move By This ThursdayBitcoin Breakout: What Most Investors Are Missing Washington just approved more crypto legislation in 90 da...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionomics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
